Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Genitourinary 1 Classical hematology 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Fluorodeoxyglucose F18 3 pembrolizumab 2 sacituzumab govitecan 1 ibrutinib 1 erdafitinib 1 enzalutamide 1 enfortumab vedotin 1 dynorphin-converting endopeptidase 1 avelumab 1 apixaban 1 Vinblastine 1 Surveys and Questionnaires 1 Specimen Handling 1 Radiosurgery 1 Pancreatectomy 1 Paclitaxel 1 Nivolumab 1 Methotrexate 1 Magnetic Resonance Imaging 1 JNJ-64619178 1 JNJ-64264681 1 Inosine Monophosphate 1 Health Information Exchange 1 Genetic Testing 1 Genetic Counseling 1 Gemcitabine 1 Focus Groups 1 Enoxaparin 1 Docetaxel 1 Cystoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Enoxaparin × Genitourinary × Clear all

NCT06243510 2026-01-28

CARE

Abramson Cancer Center at Penn Medicine

Phase NA Enrolling by invitation

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡